Protease-Activated Receptor-2-Mediated Proliferation and Collagen Production of Rat Pancreatic Stellate Cells
Open Access
- 1 February 2005
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 312 (2) , 651-658
- https://doi.org/10.1124/jpet.104.076232
Abstract
Activated pancreatic stellate cells (PSCs) play a pivotal role in the pathogenesis of pancreatic inflammation and fibrosis. Trypsin and tryptase, which are agonists for protease-activated receptor-2 (PAR-2), are involved in the pathogenesis of pancreatitis. Here, we examined whether PSCs expressed PAR-2 and its agonists affect the cell functions of PSCs. PSCs were isolated from rat pancreas tissue. Expression of PAR-2 was examined by Western blotting and reverse transcription-polymerase chain reaction. Trypsin, activating peptide (SLIGRL-NH2, corresponding to the PAR-2 tethered ligand), and tryptase were tested for their ability to affect proliferation, chemokine production, and collagen synthesis in culture-activated PSCs. Activation of mitogen-activated protein (MAP) kinases was assessed by Western blotting using antiphosphospecific antibodies. The effect of PAR-2 agonists on the activation of freshly isolated PSCs in culture was also examined. PAR-2 expression was observed in culture-activated PSCs, whereas it was undetectable in freshly isolated PSCs. PAR-2 agonists activated activator protein-1 and MAP kinases (extracellular signal-regulated kinase, c-Jun N-terminal kinase, and p38 MAP kinase) but not nuclear factor κB. PAR-2 agonists induced proliferation of PSCs through the activation of extracellular signal-regulated kinase. PAR-2 agonists increased collagen synthesis through the activation of c-Jun N-terminal kinase and p38 MAP kinase. PAR-2 agonists did not induce the production of monocyte chemoattractant protein-1 and cytokine-induced neutrophil chemoattractant-1 or initiate the transformation of freshly isolated PSCs in culture. Taken together, our results suggest a role of PAR-2 in the sustenance of pancreatic fibrosis through the increased proliferation and collagen production in PSCs.This publication has 40 references indexed in Scilit:
- A c-Jun NH2-Terminal Kinase Inhibitor SP600125 (Anthra[1,9-cd]pyrazole-6 (2 H)-one) Blocks Activation of Pancreatic Stellate CellsThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Rho kinase inhibitors block activation of pancreatic stellate cellsBritish Journal of Pharmacology, 2003
- Inhibition of p38 Mitogen-Activated Protein Kinase Blocks Activation of Rat Pancreatic Stellate CellsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Agonists of Proteinase-Activated Receptor 2 Induce Cytokine Release and Activation of Nuclear Transcription Factor κB in Human Dermal Microvascular Endothelial CellsJournal of Investigative Dermatology, 2002
- Differential Expression of Protease-Activated Receptors-1 and -2 in Stromal Fibroblasts of Normal, Benign, and Malignant Human TissuesThe American Journal of Pathology, 2001
- Identification, culture, and characterization of pancreatic stellate cells in rats and humansGastroenterology, 1998
- Periacinar stellate shaped cells in rat pancreas: identification, isolation, and cultureGut, 1998
- Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis.Journal of Clinical Investigation, 1997
- The Proteinase-activated Receptor 2 Is Induced by Inflammatory Mediators in Human Endothelial CellsJournal of Biological Chemistry, 1996
- Regulatory Role of Ceramide in Interleukin (IL)-1β-induced E-selectin Expression in Human Umbilical Vein Endothelial CellsPublished by Elsevier ,1996